Argentina Cannabis & Hemp News

03/26/2020 - 4:07pm
RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution
(Argentina, Brazil, Cannabis, CBD, Development, Distribution, Events, Growing, Investing, Law, Management, Manufacturing, Paraguay, Peru, Product Development, Production, Products, Recreational, Regulations, Subsidiaries, Testing, United States, Uruguay, THC, Recreational Cannabis, Pharmaceuticals, Cultivation) RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM ), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has approved and registered XALEX 10 (cannabidiol) oral solution, a prescription pharmaceutical formulation of highly-purified, plant-derived cannabidiol (CBD) free of tetrahydrocannabinol (THC), for the treatment of refractory epilepsy. RAMM has also been granted a license expansion and approval by the Instituto de Regulación y Control de Cannabis (“IRCCA”) for additional proprietary cannabis-based products and to include certain products for veterinary use, further expanding the Company’s robust portfolio of product offerings to the Latin American market. “The approval of XALEX 10 is a significant accomplishment for RAMM Pharma, offering patients another federally approved pharmaceutical CBD medicine,” stated Jack...
https://investingnews.com/daily/cannabis-investing/ramm-pharma-corp.receives-fed…
03/26/2020 - 9:12am
MJNA
 Medical Marijuana, Inc. (MJNA) CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19
(Argentina, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, New York, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry. The March 25, 2020, Reuters article entitled “As customers hoard pot brownies, North American weed firms see lockdown boost,” provided coverage of a recent surge in cannabis sales during the COVID-19 pandemic and quoted Titus as saying: “We have seen stockpiling in Canada by consumers who have snapped up products from LPs (licensed producers).” According to the article, cannabis retailers in both the U.S. and Canada are seeing a sharp increase in sales, including a 50 percent spike...
https://marijuanastocks.com/mjna-ceo-featured-in-reuters-coverage-highlighting-t…
03/26/2020 - 2:24am
AXIM, MJNA
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
(Acquisition, Argentina, AXIM, AXIM Biotechnologies, Brazil, Cannabis, CBD, Delivery Systems, Development, Hemp, Investment, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Monitoring, Paraguay, Products, Research, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) SAN DIEGO, March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc . (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire. As part of the acquisition, AXIM has acquired 100 percent of the capital stock of Sapphire and will operate Sapphire as a wholly-owned subsidiary. Sapphire will continue to be led by Catalina Valencia as Chief Executive Officer. Ms. Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. “Sapphire Biotech has already proven itself to have great potential...
https://cannabislaw.report/medical-marijuana-inc-investment-company-axim-biotech…
03/25/2020 - 9:00am
It Takes The Village
(Argentina, Banking, Bar, Brazil, California, Cannabis, CBD, Facilities, Genetics, Grower, Growing, Medical Marijuana, Regulations, Spain, Strains, Testing, United States, Lights, Dispensaries, Extracts, Cultivation) When people talk about California’s legendary cannabis, they frequently mention growing ganja grown deep in the Emerald Triangle and weed sparked up on the bustling streets of Los Angeles and San Francisco. But there’s another region in the Golden State that is now demanding attention. Since California’s adult-use cannabis market came online in 2018, Sacramento has exploded onto the scene as a hub of top-shelf indoor cultivation. Few people in town — perhaps only Gov. Gavin Newsom — have helped push Sacramento to the top of the cannabis stratosphere more than its cultivators, who are growing some of the best cannabis in the world. But in recent years, one local cultivator has pushed the envelope so far that everyone else in town (and across the state) is now growing the genetics he’s helped curate and breed. As half of Symbiotic Genetics , The Village finds himself among a small group of cultivators giving Sacramento’s cannabis a global reach. At one point, there was so much of his...
https://cannabisnow.com/it-takes-the-village/
03/24/2020 - 12:58pm
AXIM, MJNA
Medical Marijuana, Inc. (MJNA) Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
(Acquisition, Argentina, AXIM, AXIM Biotechnologies, Brazil, California, Cannabis, CBD, Delivery Systems, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Monitoring, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc. Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire. As part of the acquisition, AXIM has acquired 100 percent of the capital stock of Sapphire and will operate Sapphire as a wholly-owned subsidiary. Sapphire will continue to be led by Catalina Valencia as Chief Executive Officer. Ms. Valencia has stewarded Sapphire in the...
https://marijuanastocks.com/mjna-completes-acquisition-of-oncology-research-and-…
03/19/2020 - 9:20am
MJNA
Medical Marijuana, Inc. (MJNA) Receives Patent in Australia for Its Novel Monotherapeutic Compounds
(Argentina, Australia, Biotechnology, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, Hemp, India, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has been issued Australian Patent AU2015204609B2 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy.” With this Patent, Kannalife now holds seven patents across the globe. “Medical Marijuana, Inc. and our portfolio of companies such as Kannalife are committed to widening knowledge and acceptance of cannabis and cannabinoid-related studies around the world,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “...
https://marijuanastocks.com/mjna-receives-patent-in-australia-for-its-novel-mono…
03/17/2020 - 9:35am
MJNA
Medical Marijuana, Inc. (MJNA) Becomes First Company to Legally Import CBD Products Into Russia
(Argentina, Brazil, Bulgaria, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Kazakhstan, Kyrgyzstan, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Oils, Paraguay, Products, Research, Russia, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Becomes First Company to Legally Import CBD Products Into Russia Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has been granted Russia’s first-ever certificate to legally import cannabidiol (CBD) products into the country. According to the certificate, Kannaway® “is the first company in the Russian Federation to have cannabidiol in its products.” This certification allows Kannaway® to import its wide range of CBD products into the country, including the Company’s popular tinctures, oils, skincare products and more. “We have achieved a huge milestone for both Kannaway and Russia with this certificate,” said Kannaway® CEO Blake Schroeder. “No other CBD products have legally been imported and sold to Russian consumers...
https://marijuanastocks.com/mjna-becomes-first-company-to-legally-import-cbd-pro…
03/14/2020 - 6:08am
MJNA
Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, United States, Industrial Hemp, Pharmaceuticals) SAN DIEGO, March 12, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway® , has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017. ECHO Connection is a non-profit organization that aims to educate and support those pursuing cannabinoids for their therapeutic benefits in a trustworthy, safe environment. The organization strives to offer charitable support to ease the burden on families of children with disabilities or special needs. Additionally, ECHO connects families in need with doctors that can help them through an individualized comprehensive approach consisting of education and collaboration. “While CBD has become an emerging and accelerating market in the overall ‘...
https://cannabislaw.report/medical-marijuana-inc-portfolio-of-companies-celebrat…
03/12/2020 - 10:22am
MJNA
Medical Marijuana, Inc. (MJNA) Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway®, has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017. ECHO Connection is a non-profit organization that aims to educate and support those pursuing cannabinoids for their therapeutic benefits in a trustworthy, safe environment. The organization strives to offer charitable support to ease the burden on families of children with disabilities or special needs. Additionally, ECHO connects families in need with doctors that can help them through an individualized comprehensive approach consisting of...
https://marijuanastocks.com/mjna-portfolio-of-companies-celebrates-2-million-mil…
03/06/2020 - 10:59am
MJNA
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)
(Argentina, Australia, Biotechnology, Brazil, California, Canada, Cannabis, CBD, Development, Events, Food, France, Germany, Growing, Hemp, India, Investment, Investors, Italy, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Spain, United Kingdom, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) SAN DIEGO, March 5, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the European Patent Office has issued European Patent EP3094318B1 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy” to its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE). This is the sixth patent grant that Kannalife has received. Kannalife will utilize the patent to further explore the application and potential of new molecular entities (NMEs) across epilepsy, neuropathic pain, traumatic head injury, stroke, Chronic Traumatic Encephalopathy (CTE), Post Cardiac Arrest Hypoxic Ischemic Encephalopathy, Epileptic Encephalopathy, and neurodegenerative diseases such as Parkinson’s disease, Alzheimer...
https://cannabislaw.report/medical-marijuana-inc-portfolio-investment-company-ka…
03/05/2020 - 3:11am
ACB, APHA, CMED
The Future of Cannabis is All About Delivery (APHA, MMNFF, SGMD, UBER, ACB, TLRY, GRUB, AMZN)
(ACB, Acquisition, APHA, Aphria Inc., Argentina, Aurora Cannabis Inc., Australia, California, Canada, Cannabis, CanniMed Ltd., Chile, CMED, Consulting, Consumer Goods, Croatia, Cyprus, Czech Republic, Development, Distribution, Facilities, Florida, Food, Germany, Greenhouses, Investment, Investments, Investors, Legalization, Management, Manufacturing, Marketing, Medical Marijuana, Nevada, New York, New Zealand, Organic, POS, Processing, Production, Products, Recreational, Regulations, Research, South Africa, Subsidiaries, Tracking, United States, Vertically Integrated, Websites, Lights, Pharmaceuticals, Cultivation) As the Cannabis space continues to mature as a legitimate commercial marketplace, there are a number of dynamics we can expect to appear and change the game. One, in particular, seems likely to offer investors a big opportunity: Delivery. With mobile ordering, real-time geospatial tracking, and sophisticated logistical processes in place, developed in industries like supply chain management and food distribution, the infrastructure and knowledge capital is already developed for transportation into other industries for efficient deployment. And newly emerging consumer growth markets are the most obvious implementation. Cannabis is already huge and it’s going to get a whole lot bigger as the legal obstacles are inexorably toppled over coming quarters and years. It’s just a matter of time before millions of people will be going to their mobile phones and tapping a pot-leaf symbol to open up an app and order some weed. But there’s three ways it might go: Current leading players in the...
https://mmjreporter.com/the-future-of-cannabis-is-all-about-delivery-apha-mmnff-…
02/28/2020 - 5:04am
I wrote a book about global cannabis laws, here is what I learned…
(Advertising, Alcohol, Argentina, Australia, Bitcoin, Canada, Cannabis, CBD, Compliance, Digital Currency, Events, Georgia, Greece, Growing, India, Ireland, Italy, Law, Luxembourg, Malta, Marketing, Media, Mexico, Products, Recreational, Regulations, Research, Science, South Africa, Switzerland, Testing, Tobacco, United States, Uruguay, Digital Currencies, THC, Recreational Cannabis) It took twelve months of research, investigations and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional . It is a detailed analysis of medicinal and recreational cannabis laws and regulations in the most active international jurisdictions, scoping out where change is happening. It contains interviews with experts all along the chain from UN down to individual country level, and is a business tome for professionals looking to gain some legal and regulatory insight, however no prior knowledge of cannabis is presumed or necessary. Writing for Cannabis Law Report over the last year and a bit helped lay the groundwork for the book and introduce me to a network of fantastic thinkers and legal minds, allowing me to report on what is going on and gain a unique perspective of the big picture. Taking a step back, and a deep breath, I have considered...
https://cannabislaw.report/i-wrote-a-book-about-global-cannabis-laws-here-is-wha…
02/27/2020 - 10:51am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation
(Argentina, Brazil, California, Cannabis, CBD, Development, Distributor, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has launched a new high-cannabidiol (CBD) formulation of its popular Active Relief Roll-On topical product. “In addition to their many potential wellness benefits, topical CBD products have expanded the world’s acceptance of hemp and cannabinoids,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “People have a general understanding that applying a lotion isn’t going to get you high or impact your cognitive function, they’re more willing to try CBD topical products than something they might have to take orally and from there may become curious to learn what it really is and does.” HempMeds® Active Relief Roll...
https://marijuanastocks.com/mjna-subsidiary-of-medical-marijuana-inc-launches-ne…
02/25/2020 - 9:30am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary HempMeds® Brasil Sponsors Autism Event
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22. “We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world.” In...
https://marijuanastocks.com/mjna-subsidiary-hempmeds-brasil-sponsors-autism-even…
02/20/2020 - 9:31am
MJNA
 Medical Marijuana, Inc. (MJNA) Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio
(Argentina, Biotechnology, Brazil, California, Cannabis, CBD, China, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Production, Products, Research, Stocks, United States, Industrial Hemp, Patents, Pharmaceuticals, Intellectual Property) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that China has issued Chinese Patent CN106456573B (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy” to its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTC: KLFE). The Patent strengthens Kannalife’s patent portfolio of cannabidiol (CBD)-like molecules. Kannalife’s intellectual property estate of CBD-like molecules (“KLS Family”), which is led by KLS-13019, are capable of acting as neuroprotective agents and have the potential to reverse chemotherapy induced neuropathic pain. Under the Patent, Kannalife will...
https://marijuanastocks.com/mjna-portfolio-investment-company-kannalife-inc-stre…
02/18/2020 - 10:57am
MJNA
Medical Marijuana, Inc. (MJNA) Appoints Squar Milner LLP as New Independent Auditor
(Argentina, Brazil, California, Cannabis, CBD, Consulting, Consulting Services, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that it has appointed Squar Milner LLP (“Squar Milner”) as the Company’s new independent registered public accounting firm. Squar Milner will begin work immediately on the audit of Medical Marijuana, Inc.’s December 31, 2019 consolidated balance sheet. “After a thorough selection process, we are delighted to welcome Squar Milner as our independent auditor. The firm’s experience auditing companies that that are publicly listed in the U.S. offers us a wealth of talent, expertise and resources,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We look forward to seeing our 2019 audit that Squar Milner is currently working on and plan to maintain a long-term relationship with them.” Squar Milner is one of the nation’s top 50 largest accounting firms, as well as one of the largest independent accounting and advisory firms in California. They...
https://marijuanastocks.com/mjna-appoints-squar-milner-llp-as-new-independent-au…
02/14/2020 - 12:38pm
Exclusivo: Dakillah Tira Un Freestyle Sobre Cannabis Y Habla De Su Amor Por La Planta
(Argentina, Cannabis, China) Hoy hablamos con Dakillah, la rappera Argentina que asesina con sus rimas, y con style, el game domina. La Dakillah anda re china desde que era una wachina, pero es pura disciplina. Practicaba en la esquina, en las plazas, y en Brasil; de Devoto hasta Floripa, Dakillah tirando free. ¿Que carajo hacía ahí? Yo también […] The post Exclusivo: Dakillah Tira Un Freestyle Sobre Cannabis Y Habla De Su Amor Por La Planta appeared first on High Times .
https://hightimes.com/culture/music/exclusivo-dakillah-tira-un-freestyle-sobre-c…
02/14/2020 - 2:38am
CGC, CGRW, MJNA, OTC:HEMP, BNRDF, TWMJF
Preparing for Green Wave 3.0: The Shopping List (HEMP, CGRW, GTEH, CGC, TLRY, MJNA)
(Acquisition, Argentina, Australia, Bedrocan Cannabis Corp., Beverage, BNRDF, Canada, Cannabis, CannaGrow Holdings, CannaGrow Holdings, Inc, CBD, CGC, CGRW, Chile, Colorado, Consulting, Croatia, Cyprus, Czech Republic, Development, Distribution, Facilities, Food, Genetics, Germany, Grow Facilities, Grower, Growing, Hemp, Hemp Products, Hemp, Inc., Investment, Management, Manufacturing, Marketing, Medical Marijuana, Medical Marijuana Inc, MJNA, New Zealand, North Carolina, Oils, Organic, OTC:HEMP, Packaging, Processing, Production, Products, Research, South Africa, Staffing, Stocks, Testing, Tracking, Tweed Marijuana Inc, TWMJF, United States, Industrial Hemp, THC, Extracts, Pharmaceuticals, Cultivation, Holding Company) You know it’s coming. It’s just a matter of when, not if. Stocks in the hemp, CBD, and cannabis space are oversold, overly beaten down, and sorely undervalued on a macro basis given the big-picture process underway driving the mainstreaming of this formerly niche market. This is 5th grade arithmetic. It doesn’t take an Ivy League MBA to see the inevitability of the long-term trend. The only real drama here is whether it starts this month or in April, or June. We’re talking about an end-market that is set to grow by triple-digit percentage leaps every year for the next half decade at least. This is the sound of inevitability. And that sound needs an investor shopping list. We submit the following: Hemp Inc (OTCMKTS:HEMP), Cannagrow Holdings Inc (OTCMKTS:CGRW), GenTech Holdings, Inc. (OTCMKTS:GTEH), Canopy Growth Corp (NYSE:CGC), Tilray Inc (NASDAQ:TLRY), and Medical Marijuana Inc (OTCMKTS:MJNA). Hemp Inc (OTCMKTS:HEMP) just announced that its wholly-owned subsidiary, Industrial Hemp...
https://mmjreporter.com/preparing-for-green-wave-3-0-the-shopping-list-hemp-cgrw…
02/13/2020 - 10:01am
MJNA
Medical Marijuana, Inc. (MJNA) Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA
(Argentina, Biotechnology, Brazil, California, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Pennsylvania, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, has completed its phase 1 study funded by a grant (1R41DA044898-01) from the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA). The study was performed by Kannalife and the Lewis Katz School of Medicine at Temple University (LKSOM) to assess KLS-13019, Kannalife’s patented cannabidiol (CBD)-like molecule, as a potential treatment of neuropathic pain and drug dependence. “KLS-13019 continues to...
https://marijuanastocks.com/mjna-portfolio-investment-company-kannalife-inc-anno…
02/11/2020 - 9:25am
MJNA
 Medical Marijuana, Inc. (MJNA) Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise
(Argentina, Brazil, California, Cannabis, CBD, Compliance, Development, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Flagship CBD Oil RSHO-X Clinical Study Results Show Promise Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE), an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience. “We are encouraged by the study’s results and look forward to understanding more about CBD’s potential effects as we continue to conduct research on this topic,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “There are many people who are already using our products to experience a variety of health and wellness benefits. We believe that with the added assurance of these results, there will be...
https://marijuanastocks.com/mjna-flagship-cbd-oil-rsho-x-clinical-study-results-…
02/07/2020 - 3:32pm
Centurion Executes Definitive Agreement with Uruguay Cannabis CBD Oil Extraction Group
(Acquisition, Argentina, Cannabis, CBD, CBG, Consumer Products, Development, Distribution, Extraction, Fertilizer, Financing, Genetics, Investing, Investment, Investors, Management, New York, Paraguay, Peru, Processing, Products, Regulations, Training, United States, Uruguay, Pharmaceuticals, Cultivation, Real Estate) Centurion Minerals Ltd. (TSXV:CTN) (“Centurion”, or the “Company”) is pleased to announce that it has entered into a Definitive Agreement dated February 05, 2020, with a Uruguay group of companies doing business as “CannaEden”, whereby Centurion will acquire 100% of the outstanding shares and assets of CannaEden in exchange for common shares of Centurion (the “Acquisition”). The Acquisition will constitute a change of business (“COB”) of the Company. About CannaEden The CannaEden team has more than 20 years’ experience with cannabis cultivation and CBD industrialization. The CannaEden assets include: A fully funded and operational CBD extraction pilot plant capable of processing cannabis biomass to produce up to 9 kilograms/day of CBD isolate; 100% ownership of a Uruguayan tax-free zone registered company that holds a “build to suit” lease agreement on a facility that will be utilized to house a commercial GMP quality laboratory capable of producing 130 kilograms/day of CBD/CBG pharma...
https://investingnews.com/daily/cannabis-investing/centurion-executes-definitive…
02/07/2020 - 9:13am
Dtoke, OG Del Rap, Y El Porro: ‘Me Gusta Más Estar Relax, Con La Cabeza Abierta, Pero No Abrumado’
(Argentina) Bienvenidos de regreso a nuestra serie, Las Voces Del Freestyle En América Latina, en High Times en Español. En esta tercera entrega, hablamos con una eminencia en el mundo del rap Latino, Dtoke, quien hace unos pocos días se lucía en la final Argentina de la Freestyle Master Series (FMS) con una presentación que trajo […] The post Dtoke, OG Del Rap, Y El Porro: ‘Me Gusta Más Estar Relax, Con La Cabeza Abierta, Pero No Abrumado’ appeared first on High Times .
https://hightimes.com/culture/music/dtoke-og-del-rap-y-el-porro-me-gusta-mas-est…
02/06/2020 - 9:18am
MJNA
Medical Marijuana, Inc. (MJNA) Subsidiary Kannaway® Welcomes Renowned Wellness Expert
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Science, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson, has created the world’s first cannabis fitness program and is developing a new fitness-based product line to support that program. “Kannaway aims to provide consumers from all areas of life around the world with the highest-quality wellness products that are tailored to fit their lifestyles,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This partnership with Daniel Miller will allow us to better serve our wellness-minded...
https://marijuanastocks.com/mjna-subsidiary-kannaway-welcomes-renowned-wellness-…
02/06/2020 - 8:47am
CGC, CWBHF, BNRDF, TWMJF
Why CBD is Poised for a Comeback and What to Do About It (TLRY, SKDI, CGC, CWBHF, GTEH)
(Acquisition, Argentina, Australia, Bedrocan Cannabis Corp., BNRDF, Canada, Cannabis, CBD, CGC, Chile, Compass Diversified Holdings, Croatia, CWBHF, Cyprus, Czech Republic, Distribution, Food, Foods, Genetics, Germany, Growing, Hemp, Hemp Farming, Hemp Food, Hemp Foods, Hemp Products, Investment, Investors, Kentucky, Law, Management, Medical Marijuana, New Zealand, Oils, Products, South Africa, Stocks, Supplements, Topicals, Tweed Marijuana Inc, TWMJF, United States, Industrial Hemp, Extracts) The big CBD bull market of 2019 didn’t exactly pan out like so many had believed following the landmark US Farm Bill, signed into law in December 2018. That was supposed to be the spark that lit the flame. We know end-demand growth for CBD products is there – the industry is demonstrably engaged in what analysts call “mainstreaming”: when a small, niche product market expands at an epic pace as it gets discovered by the rest of the population. In this case, experts are still looking for over 125% CAGR growth over coming years. But we also know that growth in supply has kept up with that mainstreaming expansion so far, and regulators have been slow to really help send it to the next level. In fact, the FDA has been working to set things back a bit, even going so far as to issue a warning on CBD in November 2019. That helped to set off a downside capitulation phase in many stocks with CBD in their DNA. But it hasn’t impacted the viability of the mainstreaming thesis at all. More...
https://mmjreporter.com/why-cbd-is-poised-for-a-comeback-and-what-to-do-about-it…
02/05/2020 - 8:25am
PNTV
 Player’s Network, Inc. (PNTV) Shareholder 2019 Year in Review and 2020 Outlook
(Acquisition, Argentina, Beverage, Brazil, Canada, Cannabis, CBD, CBG, CBN, Compliance, Consumer Products, Development, Distribution, Events, Extraction, Facilities, Genetics, Greenhouses, Grow Lights, Growers, Growing, Hemp, Investments, Investors, Joint Ventures, Legalization, Management, Marketing, Media, Medical Marijuana, Nevada, New York, Oils, Players Network, PNTV, Processing, Production, Products, Quality Control, Recreational, Regulations, Stocks, Tracking, United States, Uruguay, Vertically Integrated, Videos, Lights, THC, Dispensaries, Extracts, Pharmaceuticals, Cultivation, Funding, Security) Players Network, Inc. Shareholder 2019 Year in Review and 2020 Outlook Player’s Network, Inc. (OTCPINK:PNTV), a rapidly growing international company in the adult-use and medical marijuana industry, with operations in Las Vegas, Nevada and Jujuy Argentina, published a Shareholder update from CEO Mark Bradley. Please visit this link https://playersnetwork.com/2019-year-in-review/ to view the full 2019 Shareholder Update with images and videos. Dear Shareholder, 2019 was, as Dickens said, the worst of times and the best of times. It was a year of struggles. It was also a year of great accomplishments. We laid tremendous groundwork for the future prosperity of our company. Let’s address our struggles and accomplishments. After 28 years as a fully reporting public company, we struggled to get our 2018 and 2019 audits and financial statements current due to unprofessional conduct by our prior accounting firm, forcing us to sue them for damages. We are targeting the end of Q1 2020 to get...
https://marijuanastocks.com/pntv-shareholder-2019-year-in-review-and-2020-outloo…
02/04/2020 - 10:07am
MJNA
 Medical Marijuana, Inc. (MJNA) Subsidiary HempMeds® Brasil Announces New Chief Medical Officer
(Argentina, Brazil, California, Cannabis, CBD, Development, Education, Events, Food, Hemp, Investment, Investments, Investors, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Paraguay, Products, Research, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces New Chief Medical Officer Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil has appointed Dr. Rubens Wajnsztejn as the Company’s Chief Medical Officer. “More than just someone who believes in the power of cannabidiol (CBD), Dr. Wajnsztejn is an expert researcher and has direct contact with many Brazilian doctors and future health professionals who need to be educated on this compound’s potential wellness benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “He will be joining our team to help us further establish relationships with hospitals and medical practices throughout Brazil and oversee studies to test the safety and efficacy of our products.” Dr. Wajnsztejn is a neuropediatric...
https://marijuanastocks.com/mjna-subsidiary-hempmeds-brasil-announces-new-chief-…
02/02/2020 - 10:31pm
Cannabis Sustainability: Hemp Perspectives
(Argentina, Brazil, California, Canada, Cannabis, Cannabis and Hemp, Chile, Colombia, Colorado, Consulting, Containers, Development, Education, Extraction, Fabric, Florida, Food, France, Greenhouses, Growing, Hemp, Hemp Plastic, Hemp Products, Law, Legalization, Management, Manufacture, Manufacturing, Medical Marijuana, Monitoring, Organic, Packaging, Pesticide, Processing, Production, Products, Regulations, Research, Strains, Synthetic, Synthetic Cannabis, United States, Uruguay, Industrial Hemp, Soil, Pharmaceuticals, Cultivation, Security) In my previous Medics Series, I tackled the tip of the iceberg on this prescient issue facing cannabis companies across the states when I asked the question: “What about sustainability in the Florida cannabis industry? On the topic of sustainability, Florida also currently lacks a dedicated patient or clinic “cannabis collection” station for used cannabis products; an integrated program for safe disposal here in Florida must be addressed, by the Medical Marijuana Advisory Committee or other dedicated state body. For example a patient-safe, secure system of cannabis disposal could operate within Florida in the same manner as the plethora of statewide “no questions asked” needle disposal/exchange programs currently offered to the general public. Or similarly, a state cannabis collection program could operate county or city-wide, like the popular unused or expired medication collections that occur on a regular basis throughout the United States in an effort to keep these pharmaceuticals...
https://cannabislaw.report/cannabis-sustainability-hemp-perspectives/
01/29/2020 - 6:14am
MJNA
Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Growing, Hemp, Investment, Kazakhstan, Kyrgyzstan, Marketing, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Nutraceuticals, Online Store, Paraguay, Products, Research, Russia, United States, Industrial Hemp, Pharmaceuticals) SAN DIEGO, Jan. 28, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan. Kannaway® was the first direct selling company to offer hemp-derived cannabidiol (CBD) products in both the U.S. and Europe. The Company currently ships its products to over 30 countries in Europe and throughout the United States. In June 2019, Kannaway® announced its expansion into the Asian market and this expansion into Russia, Kazakhstan and Kyrgyzstan is part of the Company’s aggressive international expansion plans. “Kannaway has pioneered direct selling hemp-derived CBD in the U.S. and Europe and has been rapidly expanding as consumers in new markets are eager to try our products,” said Medical Marijuana, Inc. CEO Dr...
https://cannabislaw.report/medical-marijuana-inc-subsidiary-kannaway-expands-int…
01/28/2020 - 1:19pm
MJNA
Medical Marijuana, Inc. (MJNA) Subsidiary Kannaway® Expands Into Russia
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Food, Growing, Hemp, Investment, Investments, Investors, Kazakhstan, Kyrgyzstan, Marketing, Media, Medical Marijuana, Medical Marijuana Inc, Mexico, MJNA, Nutraceuticals, Online Store, Paraguay, Products, Research, Russia, Stocks, United States, Industrial Hemp, Pharmaceuticals) Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan. Kannaway® was the first direct selling company to offer hemp-derived cannabidiol (CBD) products in both the U.S. and Europe. The Company currently ships its products to over 30 countries in Europe and throughout the United States. In June 2019, Kannaway® announced its expansion into the Asian market and this expansion into Russia, Kazakhstan and Kyrgyzstan is part of the Company’s aggressive international expansion plans. “Kannaway has pioneered direct selling hemp-derived CBD in the U.S. and Europe and has been rapidly expanding as consumers in new markets are eager to try...
https://marijuanastocks.com/mjna-subsidiary-kannaway-expands-into-russia/
01/23/2020 - 9:09am
ACB
Searching for Big Money in the Cannabis Patch (TLRY, TMGI, ACB, CURLF)
(ACB, Argentina, Aurora Cannabis Inc., Australia, Branding, Canada, Cannabis, CBD, Celebrities, Chile, Croatia, Cyprus, Czech Republic, Development, Distribution, Distributor, Education, Events, Extraction, Florida, Food, Foods, Germany, Hemp, Hemp Products, Investors, Legalization, Marketing, Massachusetts, Media, Medical Marijuana, New Jersey, New York, New Zealand, Nutraceuticals, Organic, Packaging, Processing, Products, Regulations, Research, Seed Oil, South Africa, Subsidiaries, Training, United States, Vertically Integrated, Dispensaries, Cultivation, Intellectual Property) The cannabis bear has been roaring for a year now. But 2020 has sparked a sense of renewed hope for the patch, and we wanted to take a look at a few possible ideas for taking advantage, and pass our judgement on each in turn: Tilray Inc (NASDAQ:TLRY), Marquie Group Inc (OTCMKTS:TMGI), Aurora Cannabis Inc (NYSE:ACB), Curaleaf Holdings Inc (OTCMKTS:CURLF). Tilray Inc (NASDAQ:TLRY) engages in the research, cultivation, processing, and distribution of medical cannabis. That said, it has been trashed by the market since topping its squeeze in September 2018 near $300. The reason for all the pain is that the company is running out of money because of how expensive it is to service its debt. That’s a deadly conundrum for a company in a commodity market – which is the best way to think about cannabis and cannabis-related markets. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was...
https://www.mmjobserver.com/searching-for-big-money-in-the-cannabis-patch-tlry-t…
01/07/2020 - 9:20am
Centurion Provides Update on South American Cannabis Market Potential
(Argentina, Brazil, Cannabis, CBD, Consumer Products, Development, Distribution, Extraction, Fertilizer, Financing, Investing, Investment, Investors, Legalization, Management, Paraguay, Peru, Processing, Production, Products, Regulations, Uruguay, Pharmaceuticals, Cultivation) Centurion Minerals Ltd. (TSXV:CTN) (“Centurion”, or the “Company”) reports that over the last several quarters, management has undertaken a substantive review and evaluation of legal cannabis cultivation, extraction and distribution opportunities in South America, specifically focused on low-cost, stable jurisdictions including Uruguay, Argentina, Paraguay and Peru. A significant portion of this time has been spent assessing consumer preferences and local sensitivities toward cannabis in an effort to develop a sales-focused and consumer-curated cannabis production strategy. SOUTH AMERICA Having a larger population than North America, South American countries are moving quickly with varied cannabis legalization presently rolling-out on a country-by-country basis. Brazil alone has a population exceeding 200 million and Centurion envisions a significant business opportunity there following recent cannabis legalization that prohibits any domestic production but allows importation of...
https://investingnews.com/daily/cannabis-investing/centurion-provides-update-on-…
01/07/2020 - 8:22am
Yield Growth Subsidiary Flourish Mushroom Labs Announces Agreement to Establish Laboratory to Grow and Research Psilocybin Mushrooms
(Argentina, Beverage, Brazil, Bulgaria, California, Canada, Cannabis, CBD, Colombia, Cosmetics, Costa Rica, Cyprus, Development, Distribution, Ecuador, Edibles, El Salvador, Events, Extraction, Foods, Greece, Growing, Hemp, Investing, Law, Management, Oregon, Panama, Peru, Products, Research, Romania, Saint Vincent and the Grenadines, Serbia, Strains, Subsidiaries, Testing, Topicals, United States, THC, Patents, Cultivation, Intellectual Property) The Yield Growth Corp. (CSE: BOSS , OTCQB:BOSQF, FSE:YG3) announces its subsidiary Flourish Mushroom Labs Inc. entered into a binding letter of intent on January 4, 2020 with Acres Agricultural Canada Corp. (“Acres”) to jointly form a company in Saint Vincent and the Grenadines, Acres Flourish Labs (SVG) Ltd. (“AF Labs”), to build a laboratory for the cultivation of psilocybin mushrooms and for research and development into compounds and therapeutic use of psychedelic mushrooms. Saint Vincent and the Grenadines The agreement contemplates that the proposed research and development of psilocybin for therapeutic use is within the purview of St. Vincent’s Plant Breeders’ Protection Bill, 2019 and the wider establishment of a viable and sustainable modern medicinal industry in St. Vincent and the Grenadines (“St. Vincent”). The proposing parties are aware of and keenly interested in the conducive climatic conditions as exist in Saint Vincent for the controlled cultivation of psilocybin...
https://investingnews.com/daily/cannabis-investing/yield-growth-subsidiary-flour…
01/02/2020 - 7:59am
The Yield Growth Corp. Accelerating Global Distribution and Seizing Opportunities in Psychedelic Research
(Argentina, Beverage, Brazil, Bulgaria, California, Canada, Cannabis, CBD, Colombia, Costa Rica, Cyprus, Development, Distribution, Ecuador, Edibles, El Salvador, Events, Extraction, Germany, Greece, Hemp, Investing, Law, Oregon, Panama, Partnerships, Peru, Production, Products, Research, Romania, Science, Serbia, Subsidiaries, Testing, Topicals, United States, THC, Patents, Intellectual Property) The Yield Growth Corp. (CSE: BOSS , OTCQB:BOSQF, FSE:YG3) is pleased to announce increasing global distribution of its brands. Further, the company intends to become a leader in the exciting and burgeoning psychedelic medicine industry as the company continues to build its international platform for sale of its Cannabis 2.0 and edible mushroom products. To date, Yield Growth has made significant strides since going public in December 2018, having established a broad distribution network for its various brands, exceeding 12,500 potential retail points of sale in countries throughout Europe, North America and South America. It launched 17 new products in the past year and grew its catalogue to over 200 edible, topical and wellness products. The Company’s focus in 2019 was on laying a solid foundation for future product sales by minting meaningful distribution partnerships, and in 2020 it plans to focus on advancing those relationships to get products on store shelves and in the hands of...
https://investingnews.com/daily/cannabis-investing/the-yield-growth-corp-acceler…
12/31/2019 - 3:07pm
Medical cannabis Argentina
(Argentina, Cannabis, Medical Marijuana) submitted by /u/kecuf [link] [comments]
https://www.reddit.com/r/weedstocks/comments/ei83f0/medical_cannabis_argentina/
12/31/2019 - 9:13am
Listen Live: The Yield Growth Corp. to Host Live Webcast Featuring a “2020 Outlook on the Psychedelic Mushroom Boom”
(Alcohol, Argentina, Beverage, Brazil, Bulgaria, California, Canada, Cannabis, CBD, Colombia, Cosmetics, Costa Rica, Cyprus, Deals, Development, Distribution, Ecuador, Edibles, El Salvador, Events, Extraction, Food, Foods, Greece, Growing, Hemp, Investing, Investment, Investors, Law, Management, Oregon, Panama, Peru, Products, Research, Romania, Science, Serbia, Subsidiaries, Testing, Topicals, United States, THC, Patents, Pharmaceuticals, Intellectual Property) The Yield Growth Corp. (CSE: BOSS , OTCQB:BOSQF, FSE:YG3) will host an investor conference call and webcast, on January 7th, 2020 at 1pm Eastern Standard Time, featuring a live presentation by Yield Growth CEO and Co-Founder, Penny White. Webcast: Tuesday, January 7, 2020 at 10AM PST / 1PM EST Yield Growth invites shareholders and potential investors to attend the webcast event where the company will provide an overview of what’s ahead for 2020, including exciting opportunities in functional mushrooms and psychedelic research with the launch of Yield Growth subsidiary Flourish Mushroom Labs Inc. and its line of edible mushroom products. Webcast Event Details: Date: Tuesday, January 7, 2020 Time: 10AM PST / 1PM EST Register for free here: https://www.moneyworksmagazine.com/yield-growth-corp-investor-webcast-rsvp/ An April 2019 report by Mordor Intelligence states that the global functional food market is forecasted to reach US $34.3 billion by 2024, growing at a CAGR of 8.04% between...
https://investingnews.com/daily/cannabis-investing/listen-live-the-yield-growth-…
12/27/2019 - 8:23am
NYSE:LO
Klan Y Stuart Hablan De Cannabis, El Rap, Y Ser Padres Antes De La Final De La FMS
(Argentina, Cannabis, CBD, NYSE:LO, Uruguay, THC) Cortesía de FMS Argentina. Bienvenidos de regreso a nuestra serie, Las Voces Del Freestyle En América Latina, en High Times en Español. En esta segunda entrega , hablamos con los Argentinos Stuart y Klan antes de su participación en la final nacional de la FMS, que tendrá lugar en Buenos Aires, en ­el Movistar Arena, el 28 de Diciembre. Encontrá tus entradas acá . Por más duro que se tiren sobre la tarima en la Freestyle Master Series (FMS), Klan y Stuart tienen una química especial abajo del escenario. Viajar juntos constantemente, siendo padres, y mayores que muchos de los otros freestylers, ayuda a generar un vínculo. Pero esta amistad viene con un toque de condimento extra: la buena hierba. Arrancamos la conversación con una introducción simple: vamos a hablar de faso (cannabis, marihuana, o mota). “Vamos a hablar de faso,” dicen los dos en unísono. Se miran y se rien. Es un poco surrealista. Estamos en una locación bien careta, corporativa – no podemos decir cual por el consumo...
https://hightimes.com/espanol/klan-y-stuart-hablan-de-cannabis-el-rap-y-ser-padr…
12/24/2019 - 8:38am
Yield Growth Featured in Vanity Fair UK’s Holiday Issue on Shelves Now
(Argentina, Beverage, Brazil, Bulgaria, California, Canada, Cannabis, CBD, Colombia, Cosmetics, Costa Rica, Cyprus, Development, Distribution, Ecuador, Edibles, El Salvador, Events, Extraction, Greece, Hemp, Investing, Law, Management, Oregon, Panama, Peru, Products, Research, Romania, Seed Oil, Serbia, Subsidiaries, Testing, Topicals, United States, THC, Patents, Intellectual Property) The Yield Growth Corp. (CSE: BOSS , OTCQB:BOSQF, FSE:YG3) is pleased to announce that Urban Juve’s Hydrating Body Oil appears in this month’s holiday issue of Vanity Fair UK, which features RuPaul on the cover, photographed by Annie Leibovitz. Figure 1. Vanity Fair UK Holiday Issue 2019/2020 in Stores Now! The magazine highlights Urban Juve’s Ayurveda-inspired Hydrating Body Oil in “The Vanity Box,” along with a range of other handpicked luxury beauty products, selected for the publication’s sophisticated and highly affluent readers. The Canadian-made Hydrating Body Oil is one of Urban Juve’s most popular products. Powered by hemp seed oil, avocado oil and ginger oil, Hydrating Body Oil helps revive the skin, while cinnamon and cardamom invigorate the senses. Urban Juve has been featured several times in Vanity Fair UK and other high-quality beauty and lifestyle publications, such as British Vogue and Elle Canada. “We are expecting our products to be widely distributed throughout...
https://investingnews.com/daily/cannabis-investing/yield-growth-featured-in-vani…
12/23/2019 - 6:55am
HEXO, ACB, GWPH, CGC, CRLBF, NYSE:MO
2019: The Year in Cannabis
(ACB, Acquisition, Alcohol, Altria Group Inc, Argentina, Arizona, Aurora Cannabis Inc., Australia, Banking, Brazil, California, Canada, Cannabis, CBD, CGC, Chile, Cigarettes, Colorado, Connecticut, Cresco Labs, CRLBF, Distribution, District of Columbia, Drinks, Extraction, Florida, Food, France, Growers, GW Pharmaceuticals plc, GWPH, Hemp, HEXO, Illinois, Investing, Investments, Law, Legalization, Luxembourg, Management, Massachusetts, Media, Medical Marijuana, Mexico, Netherlands, Nevada, New Jersey, New York, NYSE:MO, Oils, Oregon, Paraguay, Partnerships, Pennsylvania, Portugal, Processing, Production, Products, Quality Control, Regulations, Research, Rhode Island, Scientific Research, Stocks, The ArcView Group, Tobacco, United States, Washington, Industrial Hemp, THC, Financial Services, Pharmaceuticals, Cultivation, Security) The year 2019 has certainly been a busy one for Cannabis Wire. In September, we launched C-Wire Plus , our subscription service, which comes with our daily newsletter and access to original research and databases. Stay tuned, because we’re gearing up for a bigger 2020, and looking forward to hitting the ground again right after the holidays. If you’d like to work together in 2020, we’re actively planning editorial and business partnerships. Email anytime: editors@cannabiswire.com . Meanwhile, a look back at a year of change and at where we are now. Here are some of the major developments we covered in 2019, and will continue to cover in 2020: Northeast states are *this close* to legalizing. (And so are some others.) While New York and New Jersey lawmakers tried and failed to legalize this year, any Northeast state that hasn’t yet legalized stands a strong chance of doing so in 2020. New York Governor Andrew Cuomo hosted the Regional Cannabis Regulation and Vaping Summit in October,...
https://cannabiswire.com/2019/12/23/the-year-in-cannabis/
12/19/2019 - 8:12am
Listen Live: The Yield Growth Corp. to Release “2020 Outlook on the Psychedelic Mushroom Boom”
(Argentina, Beverage, Brazil, Bulgaria, California, Canada, Cannabis, CBD, Colombia, Cosmetics, Costa Rica, Cyprus, Deals, Development, Distribution, Ecuador, Edibles, El Salvador, Events, Extraction, Food, Foods, Greece, Growing, Hemp, Investing, Investment, Investors, Law, Management, Oregon, Panama, Peru, Products, Research, Romania, Science, Serbia, Subsidiaries, Testing, Topicals, United States, THC, Patents, Pharmaceuticals, Intellectual Property) The Yield Growth Corp. (CSE: BOSS , OTCQB:BOSQF, FSE:YG3) will host an investor conference call and webcast, on January 7th, 2020 at 1pm Eastern Standard Time, featuring a live presentation by Yield Growth CEO and Co-Founder, Penny White. Figure 1: Live Webcast and Conference Call: Tuesday, January 7th at 1pm Eastern Standard Time Yield Growth invites shareholders and potential investors to attend the webcast event where the company will provide an overview of what’s ahead for 2020, including exciting opportunities in functional mushrooms and psychedelic research with the upcoming launch of Yield Growth subsidiary, Flourish Mushroom Labs Inc. Webcast Event Details: Date: Tuesday, January 7, 2020 Time: 10AM PST / 1PM EST Register for free here: https://www.moneyworksmagazine.com/yield-growth-corp-investor-webcast-rsvp/ An April 2019 report by Mordor Intelligence states that the global functional food market is forecasted to reach US $34.3 billion by 2024, growing at a CAGR of 8.04%...
https://investingnews.com/daily/cannabis-investing/listen-live-the-yield-growth-…
12/17/2019 - 9:25am
MJNA
Medical Marijuana, Inc. (MJNA) Appoints New Chief Financial Officer
(Argentina, Brazil, California, Cannabis, CBD, Development, Events, Food, Hemp, Investment, Investments, Investors, Management, Media, Medical Marijuana, Mexico, MJNA, Paraguay, Products, Research, United States, Industrial Hemp) Medical Marijuana, Inc. Appoints New Chief Financial Officer Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company. “Brooke’s contributions to the Company have been extraordinary,” said Medical Marijuana, Inc. COO Blake Schroeder. “He’s helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency.” Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company’s accounting department, handling the Company’s budget management, public financial reports, e-commerce offerings, and forecasting needs. “Working with the Medical Marijuana, Inc. team has...
https://marijuanastocks.com/mjna-appoints-new-chief-financial-officer/
12/11/2019 - 7:00am
Argentina Launches Ambitious Effort To Research Medical Cannabis
(Argentina, Cannabis, Medical Marijuana, Research) For the last ten months Argentina’s provincial government has worked on launching a medical cannabis research effort. How will this impact the industry? Read this article >
https://cannatechtoday.com/argentina-launches-ambitious-effort-to-research-medic…
11/19/2019 - 6:20am
Wake & Bake America 938: Supporting Dudegrows, Fake Baby Bump Smuggler, & Biden And Gateway Drugs
(Argentina, Cannabis) DUDE GROWS CREW MEMBERSHIP HERE: https://www.dudegrows.com/support Or Go To www.Patreon.com/dudegrowsshow DUDE GROWS MERCH: https://www.dudegrows.com/dgc-outlet/ The Dude & Scotty Real Are Back & Hanging Out And Waking And Baking And Talking About Paypal Trying To Cancel The Dudegrows Show And How You Can Support The Show By Going To Our New Patreon In The Link Above, Using Cannabis As Medicine And Connecting With Your Family, Why TSA Precheck Is Such A Scam, Technology Taking Over Everyones Lives, A Woman In Argentina Caught Smuggling Cannabis In A Fake Baby Bump Made Of Paste, Biden And His Plan To Not Legalize Cannabis And The Perpetuation Of The Fallacy That Weed Is A Gateway Drug & Much More On Today Episode Of Wake & Bake America Dont Forget To Like & Subscribe & Share The Dudegrows Show To Help Spread The Word.
http://dudegrows.libsyn.com/wake-bake-america-938-supporting-dudegrows-fake-baby…
01/09/2019 - 5:58am
NSPDF
Hemp Seeds Market 2017 Forecast to 2022 Market Potential Growth and Market Prospects 2018-2023 in Food and Beverages
(Argentina, Beverage, Brazil, Canada, Cannabis, China, Compass Diversified Holdings, Egypt, Food, Foods, France, Germany, Hemp, India, Investors, Italy, Japan, Manufacturer, Mexico, Naturally Splendid Enterprises Ltd., Nigeria, NSPDF, Products, Research, Russia, Saudi Arabia, Seed Oil, South Africa, Industrial Hemp, THC) GLOBAL Hemp Seeds Market 2017 Forecast to 2022 Market research report 2018 will help you take informed decisions, understand opportunities, plan effective business strategies, plan new projects, analyse drivers and restraints and give you a vision on the industry forecast. Hemp Seeds Market 2017 Forecast to 2022 Market report would come in handy to understand your competitors and give you an insight about sales; volumes, revenues in the Hemp Seeds Market 2017 Forecast to 2022 industry. Both established and new players in Hemp Seeds Market 2017 Forecast to 2022 industries can use report to understand the market . Viewpoint Hemp Seeds Market 2017 Forecast to 2022 Market Forecast 2023 Hemp seeds, or hemp hearts, are the seeds of the hemp plant, or Cannabis sativa. Although marijuana comes from the same plant, hemp seeds only contain a trace amount of THC, the active ingredient in marijuana, and they will not get you high. In fact, hemp seeds are safe and very healthy to eat.Hemp Seeds...
https://www.marijuanastocksreport.com/hemp-seeds-market-2017-forecast-to-2022-ma…
12/28/2018 - 12:58pm
HITIF
Wayland Group to Explore Strategic Alternatives to Maximize Shareholder Value Including the Spinout and/or European Listing of its International Assets
(Acquisition, Argentina, Australia, Automation, Beverage, Canada, Cann Group, Cannabis, CBD, Colombia, Development, Distribution, Distributor, Extraction, Facilities, Germany, Grower, Hemp, High Tide, HITIF, Investment, Italy, Legalization, Malta, Management, Manufacture, Manufacturing, Medical Marijuana, Online Store, Organic, Partnerships, Processing, Production, Products, Research, Strains, Subsidiaries, Switzerland, United Kingdom, Vertically Integrated, Wine, Industrial Hemp, THC, Pharmaceuticals, Cultivation) Wayland Group to Explore Strategic Alternatives to Maximize Shareholder Value Including the Spinout and/or European Listing of its International Assets Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) , a global, vertically integrated cultivator and processor of cannabis, today announced that its Board of Directors has initiated a process to explore a broad range of strategic alternatives, including, but not limited to assessing the potential spin-out and/or European listing of its international assets in an effort to unlock the value of the Company’s vast international asset portfolio, as well as its underlying domestic Canadian assets. Any Spinout Transaction of the International Assets could include the Company’s European, Latin American, and Asia-Pacific operations. The Company strongly believes in its current strategy; however, it does not believe its current share price accurately reflects the global portfolio Wayland has, and continues to create. “We have demonstrated...
https://www.marijuanastocksreport.com/wayland-group-to-explore-strategic-alterna…
12/27/2018 - 7:35pm
APHA, NYSE:MO
Green Growth Brands Targets Aphria in Takeover Bid
(Acquisition, Alcohol, Altria Group Inc, APHA, Aphria Inc., Argentina, Beverage, Canada, Cannabis, Colombia, Deals, Financing, Investing, Investment, Investments, Investors, Jamaica, Law, Management, Medical Marijuana, New York, NYSE:MO, Partnerships, Research, Tobacco, United States) In a stunning move, a US cannabis multi-state operator has launched a takeover bid for Canadian licensed producer (LP) Aphria (NYSE: APHA ,TSX:APHA). On Thursday (December 27), Green Growth Brands (GGB) (CSE: GGB ) unveiled its intentions to pursue an offer for the major Canadian cannabis producer. Peter Horvath, CEO of GGB, said the two companies combined will accelerate the growth strategies for the Canadian, US and international markets. Keep up with major deals and investment opportunities in marijuana Learn to profit from cannabis companies Give me my free report! GGB’s offer for Aphria gives a 45.5-percent premium on the company’s closing price on the TSX on Monday (December 24). The deal is valued at C$11 per Aphria share, with shareholders receiving 1.5714 common shares of GGB for each Aphria share they own. According to the US operator, the offer values Aphria at approximately C$2.8 billion. “We are confident that the significant premium we are offering and the opportunity to...
https://investingnews.com/daily/cannabis-investing/green-growth-brands-aphria-ta…
12/24/2018 - 9:15am
Wayland Receives Additional Licensing from Health Canada
(Argentina, Australia, Automation, Canada, Cann Group, Cannabis, Colombia, Development, Distribution, Events, Extraction, Facilities, Germany, Investing, Italy, Lighting, Media, Production, Subsidiaries, Switzerland, Vertically Integrated, Cultivation) Wayland Group Corp. (CSE: WAYL ; FWB:75M; OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that as of December 21, 2018 the Company has received additional licensing for seven (7) additional grow rooms from Health Canada, for phase one of its purpose-built cannabis production facility in Langton, ON. Over the next 4 weeks the Company will transition 21,900 vegetative plants into the newly licensed rooms, three of which will be used for one cycle of flower, after which they will be used to support a perpetual cycle of cultivation as vegetation rooms. “When the Company set out on this journey, one of our core objectives was to set the standard for high quality, large scale production of cannabis that consumers can trust. Our world class facility is one step closer to accomplishing that goal as we are now able to commence the perpetual cycle of cultivation. We are confident in the AI Data Grow platform developed in conjunction with Rockwell Automation, with proof of...
https://investingnews.com/daily/cannabis-investing/wayland-receives-additional-l…
12/24/2018 - 8:40am
Wayland Group (MRRCF) Receives Additional Licensing from Health Canada
(Argentina, Australia, Automation, Canada, Cann Group, Cannabis, Colombia, Development, Distribution, Events, Extraction, Facilities, Germany, Investments, Italy, Lighting, Media, Production, Stocks, Subsidiaries, Switzerland, Vertically Integrated, Cultivation) Wayland Receives Additional Licensing from Health Canada Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that as of December 21, 2018 the Company has received additional licensing for seven (7) additional grow rooms from Health Canada, for phase one of its purpose-built cannabis production facility in Langton, ON. Over the next 4 weeks the Company will transition 21,900 vegetative plants into the newly licensed rooms, three of which will be used for one cycle of flower, after which they will be used to support a perpetual cycle of cultivation as vegetation rooms. “When the Company set out on this journey, one of our core objectives was to set the standard for high quality, large scale production of cannabis that consumers can trust. Our world class facility is one step closer to accomplishing that goal as we are now able to commence the perpetual cycle of cultivation. We are confident in the AI Data Grow platform developed in conjunction...
https://marijuanastocks.com/mrrcf-receives-additional-licensing-from-health-cana…
12/21/2018 - 8:40am
Wayland Group (MRRCF) Update on 3:1 reverse stock split & AGM Results
(Argentina, Australia, Canada, Cann Group, Cannabis, Colombia, Distribution, Events, Extraction, Facilities, Germany, Investments, Italy, Media, Production, Stocks, Subsidiaries, Switzerland, Vertically Integrated, Cultivation) Wayland Update on 3:1 reverse stock split & AGM Results Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announces that the Company will no longer consider a 3:1 reverse stock split that had been previously communicated. The Company removed the item from the AGM ballot today held in Langton, Ontario, as the previously announced strategic review the Company is undergoing will take priority. “The Company is on the cusp of realizing a number of its objectives and we would not be in this position without the support of our shareholders. As we look into 2019 and beyond, the building blocks are in place for the Company to capitalize on cutting-edge technologies and the further expansion of cannabis markets around the world,” stated Ben Ward, CEO Wayland. All other items that were tabled for a shareholder vote were passed and have been put into effect by the Company. Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further...
https://marijuanastocks.com/mrrcf-update-on-31-reverse-stock-split-agm-results/
12/18/2018 - 12:57pm
Wayland Announces Significant Supply Agreement with RavenQuest BioMed
(Argentina, Canada, Cannabis, Colombia, Consulting, Development, Distribution, Events, Extraction, Facilities, Germany, Investing, Italy, Management, Media, Partnerships, Production, Recreational, Research, Research & Development, Subsidiaries, Switzerland, Vertically Integrated, Recreational Cannabis, Cultivation) Wayland Group (CSE: WAYL ) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in 2019. The total quantity will be shipped periodically throughout 2019 as product becomes available. As part of the supply agreement, Wayland will make an immediate one-time payment of $2 million to RavenQuest in anticipation of the first major shipment of cannabis flower in March 2019. Pricing for the transaction is comparable with prevailing wholesale cannabis prices. “RavenQuest is very excited to be working with Wayland as we both do our part to meet the huge demand for cannabis across Canada,” stated George Robinson, CEO of RavenQuest. “Negotiations were smooth and without major challenges; Ben Ward and his team at Wayland are a pleasure to work with. This supply agreement is a significant win...
https://investingnews.com/daily/cannabis-investing/wayland-announces-significant…
12/14/2018 - 12:50pm
Cannabis Big News Roundup: Koios Secures Agreement With GNC; High Tide to Acquire Grasscity; Green Growth Brands Acquires Just Healthy LLC
(Argentina, Cannabis, CBD, Extraction, Growing, Investing, Manufacturing, Products, Strains, Cultivation) In case you missed it, here is this week’s big news roundup for cannabis: High Tide to Acquire Grasscity – the World’s Most Popular Online Retailer of Smoking Accessories – and the Grasscity Forums Valens Signs Multi-year Cannabis Extraction Agreement with Canopy Growth Khiron Life Sciences Completes Acquisition of ILANS Indiva Successfully Imports 3 Premium CBD Strains From Swiss Cannabis Producer CROP’S Italian Greenhouse Ready for the 2019 Growing Season FinCanna Portfolio Company, Refined Resin Technologies Acquires Key Manufacturing License GTEC Holdings Announces OTCQB Listing and DTC Eligibility Redfund Portfolio Clients Form Strategic Alliance to Launch Branded Products Green Growth Brands Announces the Acquisition of Just Healthy LLC Koios Secures Vendor Agreement With Retail Giant GNC James E. Wagner Cultivation Receives Building Permit for Continued Large Scale Expansion at Second Facility Wayland Group Announces Strategic Acquisition in Argentina Grown Rogue Launches...
https://investingnews.com/daily/cannabis-investing/cannabis-big-news-roundup-dec…